« Happy Canadian Thanksgiving! | Main | Teva Pharmaceutical Industries Announces FDA Approval of Actonel »

Oct 9
Xeloda (capecitabine) Better than Traditional Chemo

Roche Holding AG's (OTC:RHHBY) Xeloda, which is the first FDA approved oral chemotherapy for metastatic breast and colorectal cancer, has proven to be more convenient and have fewer side effects than traditional chemotherapy.

Xeloda.jpgIn a study of almost 2000 patients, research showed that 71% of patients were still alive after 5 years, after having been given Xeloda, as compared to 68% of those that received standard chemotherapy injections. The study also showed that patients treated with Xeloda spent 85% less time with their doctor or in hospitals and experienced fewer side effects.

"Standard chemotherapy can be incredibly disruptive to people's lives," said Prof Professor Chris Twelves of the University of Leeds, who led the research. "Patients visit hospital five days a week for the injections and then have three weeks off before returning to hospital for the next course - and the side effects can be unpleasant."

Xeloda has also been approved, in Europe, for use with chemotherapy, for treatment of advanced stomach cancer. About 945,000 people are diagnosed annually with colorectal cancer however the disease is curable if caught early.

Check out this interesting article on Combination vs Sequential Chemotherapy for more information on studies of different colorectal cancer treatments.

 

[Source: University of Leeds]


1 Comments/Trackbacks




» Roche's Xeloda Gets EC Approval from PharmaGazette
The European Commission has approved Roche's oral chemotherapy Xeloda for treatment of metastatic colorectal cancer in combination with any chemotherapy with or without Avastin.The approval of the new indication will allow more patients that have c... [Read More]

submit a trackback

TrackBack URL for this entry:

post a comment

Name, Email Address, and URL are not required fields.





Comment Preview

« Happy Canadian Thanksgiving! | Main | Teva Pharmaceutical Industries Announces FDA Approval of Actonel »

Advertise

Watch the Digital Health Revolution


sponsored ads



subscribe


Prefer Email?
Subscribe below-

Enter your Email:


Powered by FeedBlitz What's this?

Current News

Support This Blog

top blogs

business social media

Use these fast growing business social media sites to promote your business, feature your products, spotlight your business leaders, create links, and drive traffic back to your company site, all for free!

BIZZlogos - Add your logo - free link to your site
BIZZphotos - Add photos of your products and people
BIZZprofiles - Submit your profile and build your online visibility
BIZZspotlight - Spotlight your business with free links
BIZZvideos - Videos about businesses, products and business people.
BIZZbites - "Digg" for Business - Submit your articles and posts

know more media network

View Network Map

Network Feed List (OPML)

Know More Media Network
Feed


we support unitus

PRWeb

Influencer



PharmaGazette is a member of the Know More Media network of business related blogs.

Here are some current headlines from some of our business publications:

ProductivityGoal

CallCenterScript

AdHurl

TheBizofKnowledge

LandingTheDeal

CustomersAreAlways

HealthCareVox

BrainBasedBusiness

TheInsurancePolicy

MarketingBlurb